Long intergenic non-protein coding RNA 1278 (LINC01278)

Long intergenic non-protein coding RNA 1278 (LINC01278) is a long non-coding RNA (lncRNA) located in intergenic regions of the human genome, meaning it does not encode a protein but instead regulates gene expression at the RNA level. LINC01278 exerts effects in cancer biology, functioning as a regulatory molecule that can act as a molecular sponge for certain microRNAs, thereby modulating the expression of downstream genes. It has been shown to inhibit the progression of papillary thyroid carcinoma by regulating the miR-376c-3p/DNM3 axis, suppress uveal melanoma by inducing autophagy through inhibition of the mTOR signaling pathway, and participate in the negative regulation of the Wnt/β-catenin signaling cascade, which is crucial in tumorigenesis. Clinical and experimental evidence indicates LINC01278 is downregulated in some cancers (such as uveal melanoma), where its reduced expression correlates with poorer outcomes, suggesting its utility as a biomarker for prognosis or disease aggressiveness. Though not a therapeutic protein/receptor/enzyme, LINC01278 represents a node in oncogenic regulatory networks and is being evaluated for its potential as a therapeutic RNA target, primarily through modulation of its expression or interfering RNAs in preclinical research. No approved drugs directly target LINC01278, but mechanistic studies often use small molecules (like rapamycin or 3-MA) to probe its effects in cellular pathways.

Other names

LINC01278

Not a direct therapeutic target; mechanisms involve modulation of cellular pathways (e.g., acts as a sponge for specific microRNAs, inhibits mTOR signaling to induce autophagy, promotes β-catenin degradation)